Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Does Weightbearing Crutch Technology Impact Patient Compliance?

Not Applicable

Recruiting

Conditions: Fracture Healing

Interventions: Behavioral: Weight-Bearing Feedback
Device: Smart Crutch Tip

First Posted Date: 2023-04-24

Last Posted Date: 2025-02-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT05825079

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Ladarixin With Sotorasib in Advanced NSCLC - Phase II

Phase 2

Withdrawn

Conditions: Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Interventions: Drug: Sotorasib
Drug: Ladarixin

First Posted Date: 2023-04-18

Last Posted Date: 2024-03-29

Lead Sponsor: NYU Langone Health

Registration Number: NCT05815186

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness

Not Applicable

Recruiting

Conditions: Cigarette Smoking

Interventions: Other: E-cigarette (EC)
Other: Nicotine Replacement Therapy (NRT)
Behavioral: Harm-Reduction Counseling
Behavioral: Ecological Momentary Intervention (EMI) Text Messaging

First Posted Date: 2023-04-18

Last Posted Date: 2024-10-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT05815199

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Ladarixin With Sotorasib in Advanced NSCLC

Phase 1

Recruiting

Conditions: Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Interventions: Drug: Sotorasib
Drug: Ladarixin

First Posted Date: 2023-04-18

Last Posted Date: 2025-02-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT05815173

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

Not Applicable

Recruiting

Conditions: Deafness

Interventions: Device: Electrode-Neural Interface

First Posted Date: 2023-04-12

Last Posted Date: 2025-02-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 200

Registration Number: NCT05810220

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Daratumumab in STK11 Mutated NSCLC

Phase 2

Recruiting

Conditions: Non-small Cell Lung Cancer With STK11/LKB1 Mutation

Interventions: Drug: Daratumumab and Hyaluronidase-fihj
Drug: Pre-Intervention Medication
Drug: Post-Intervention Medication

First Posted Date: 2023-04-10

Last Posted Date: 2025-03-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 14

Registration Number: NCT05807048

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Evaluating a Noise Reduction Algorithm With Cochlear Implant Users

Not Applicable

Recruiting

Conditions: Hearing Impairment

Interventions: Device: SEDA

First Posted Date: 2023-04-10

Last Posted Date: 2024-12-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT05805384

Locations: 🇺🇸
Tisch Hospital, New York, New York, United States

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

Phase 3

Recruiting

Conditions: Systemic Lupus Erythematosus

Interventions: Drug: Placebo
Drug: Hydroxychloroquine

First Posted Date: 2023-04-05

Last Posted Date: 2025-04-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 330

Registration Number: NCT05799378

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸
VA NY Harbor Healthcare System, New York, New York, United States

and more 7 locations

Stress & Self-Control Costs

Not Applicable

Recruiting

Conditions: Self-Control

Interventions: Behavioral: Cold-Pressor Task (CPT)
Behavioral: Trier Social Stress Test (TSST)
Behavioral: Modified Non-Stress CPT
Behavioral: Modified Non-Stress TSST
Device: Functional Magnetic Resonance Imaging (fMRI)

First Posted Date: 2023-04-03

Last Posted Date: 2025-04-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 300

Registration Number: NCT05795179

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease

Not Applicable

Recruiting

Conditions: Ischemic Heart Disease

Interventions: Procedure: GeriKit Mobile Application

First Posted Date: 2023-03-29

Last Posted Date: 2025-01-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 150

Registration Number: NCT05788666

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy